Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies

Clinical trial NCT05042908 · COMPLETED

Trial details

NCT number: NCT05042908
Sponsor: Nanjing Leads Biolabs Co.,Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2021-12-02
Primary completion: 2023-04-10
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.